Data / Form D filings / KPI Therapeutics, Inc.
KPI Therapeutics, Inc.: Form D filings
KPI Therapeutics, Inc., a biotechnology company in Seattle, WA, filed 4 Form D notices with the SEC between 2014 and 2016. The latest, on December 5, 2016, reports $18,000 sold of a $3 million offering to 1 investor.
Find out what KPI Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 401 TERRY AVENUE NORTH, 4TH FLOOR, Seattle, WA, 98109
- Phone
- (206) 378-0400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1607700
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 5, 2016 | New notice | $3,000,000 | $18,000 | $2,982,000 | 1 | Dec 2, 2016 | sec.gov |
| Feb 16, 2016 | New notice | $7,500,000 | $50,500 | $7,449,500 | 1 | Feb 3, 2016 | sec.gov |
| May 19, 2015 | New notice | $7,000,000 | $27,000 | $6,973,000 | 2 | May 6, 2015 | sec.gov |
| May 16, 2014 | New notice | $10,000,000 | $1,627,498 | $8,372,502 | 43 | May 5, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Shawn E Iadonato | Director | |
| James G. W. E Reed | Director | |
| Ray E Bartoszek | Director | |
| Craig E Philips | Executive Officer | |
| Paul E Sylvester | Director | |
| Charles L. Magness | Executive Officer, Director | |
| Steven E Mitchel | Director | |
| Don E Merlino | Director | |
| Thomas E Hornish | Executive Officer |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Dec 5, 2016 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what KPI Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.